Bratica Joseph 4
4 · Sarepta Therapeutics, Inc. · Filed Aug 5, 2020
Insider Transaction Report
Form 4
Bratica Joseph
Principal Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2020-08-03$29.60/sh+1,125$33,300→ 8,957 total - Sale
Common Stock
2020-08-03$155.00/sh−1,125$174,375→ 7,832 total - Exercise/Conversion
Stock Option (right to buy)
2020-08-03−1,125→ 5,625 totalExercise: $29.60From: 2018-03-31Exp: 2027-03-31→ Common Stock (1,125 underlying)
Footnotes (1)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person. Accordingly, the reporting person had no discretion with regards to the timing of the transaction.